Article
Wild-type and pathogenic forms of ubiquilin 2 differentially modulate components of the autophagy-lysosome pathways.
Journal of pharmacological sciences - 1 Jul 2023
Idera Akiko, Sharkey Lisa M, Kurauchi Yuki, Kadoyama Keiichi, Paulson Henry L, Katsuki Hiroshi, Seki Takahiro
Abstract excerpt
Missense mutations of ubiquilin 2 (UBQLN2) have been identified to cause X-linked amyotrophic lateral sclerosis (ALS). Proteasome-mediated protein degradation is reported to be impaired by ALS-associated mutations of UBQLN2. However, it remains unknown how these mutations affect autophagy-lysosome protein degradation, which consists of macroautophagy (MA), microautophagy (mA), and chaperone-mediated autophagy...
Topics
- Humans
- Amyotrophic Lateral Sclerosis
- Adaptor Proteins, Signal Transducing
- Autophagy
- Mutation
- Autophagy-Related Proteins
- Transcription Factors
- Lysosomes
